End-of-day quote
Shanghai S.E.
06:00:00 2024-05-20 pm EDT
|
5-day change
|
1st Jan Change
|
130
CNY
|
-4.17%
|
|
-5.89%
|
-4.19%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
26,600
|
18,866
|
18,076
|
-
|
-
|
Enterprise Value (EV)
1 |
26,600
|
18,866
|
18,076
|
18,076
|
18,076
|
P/E ratio
|
74.8
x
|
56.3
x
|
32.6
x
|
24.3
x
|
21.4
x
|
Yield
|
0.13%
|
0.25%
|
0.22%
|
0.3%
|
0.37%
|
Capitalization / Revenue
|
39.6
x
|
20.6
x
|
14.7
x
|
10.3
x
|
8.75
x
|
EV / Revenue
|
39.6
x
|
20.6
x
|
14.7
x
|
10.3
x
|
8.75
x
|
EV / EBITDA
|
69.2
x
|
66
x
|
31.6
x
|
21.2
x
|
18.3
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
6.99
x
|
4.49
x
|
3.87
x
|
3.33
x
|
2.96
x
|
Nbr of stocks (in thousands)
|
139,067
|
139,067
|
139,067
|
-
|
-
|
Reference price
2 |
191.3
|
135.7
|
130.0
|
130.0
|
130.0
|
Announcement Date
|
2/26/23
|
1/31/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
672.4
|
917.5
|
1,226
|
1,761
|
2,067
|
EBITDA
1 |
-
|
384.1
|
285.7
|
572.7
|
851.1
|
988.8
|
EBIT
1 |
-
|
373.9
|
265.3
|
559
|
835.1
|
953.7
|
Operating Margin
|
-
|
55.61%
|
28.91%
|
45.59%
|
47.41%
|
46.15%
|
Earnings before Tax (EBT)
1 |
-
|
377.9
|
270.3
|
559.1
|
834.3
|
953.6
|
Net income
1 |
233.2
|
333.4
|
335
|
504
|
742.9
|
846.5
|
Net margin
|
-
|
49.59%
|
36.52%
|
41.1%
|
42.18%
|
40.96%
|
EPS
2 |
2.234
|
2.557
|
2.410
|
3.991
|
5.342
|
6.088
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.2416
|
0.3400
|
0.2800
|
0.3950
|
0.4850
|
Announcement Date
|
2/15/22
|
2/26/23
|
1/31/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
11.5%
|
8.39%
|
10.7%
|
13.6%
|
13.7%
|
ROA (Net income/ Total Assets)
|
-
|
13.4%
|
-
|
9.43%
|
12.4%
|
12.2%
|
Assets
1 |
-
|
2,494
|
-
|
5,347
|
6,016
|
6,927
|
Book Value Per Share
2 |
-
|
27.40
|
30.20
|
33.60
|
39.10
|
43.90
|
Cash Flow per Share
2 |
-
|
1.290
|
0.5400
|
3.560
|
3.820
|
4.280
|
Capex
1 |
-
|
332
|
462
|
241
|
195
|
253
|
Capex / Sales
|
-
|
49.35%
|
50.33%
|
19.67%
|
11.06%
|
12.24%
|
Announcement Date
|
2/15/22
|
2/26/23
|
1/31/24
|
-
|
-
|
-
|
Average target price
166.2
CNY Spread / Average Target +27.85% Consensus |
1st Jan change
|
Capi.
|
---|
| -4.19% | 2.5B | | +3.85% | 105B | | -6.59% | 62.84B | | +72.86% | 49.15B | | +15.33% | 38.45B | | +5.32% | 32.61B | | +14.73% | 20.65B | | +12.59% | 16.81B | | +18.15% | 15.14B | | +3.29% | 14.14B |
Other Commodity Chemicals
|